New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
10:02 EDTACT, JEC, MNK, MW, MYL, PKY, PRGO, SLXP, TEVA, VRX, HST, HSP, GT, ARCP, BDN, BR, CBI, CTB, DRH, ENDP, EQR, ESS, VTROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Actavis (ACT) initiated with a Buy at Deutsche Bank... American Realty (ARCP) initiated with a Perform at Oppenheimer... Brandywine Realty (BDN) initiated with a Neutral at Mizuho... Broadridge (BR) initiated with an Outperform at Raymond James... Chicago Bridge & Iron (CBI) initiated with a Market Perform at Wells Fargo... Cooper Tire (CTB) initiated with a Neutral at JPMorgan... DiamondRock (DRH) initiated with a Neutral at ISI Group... Endo (ENDP) initiated with a Buy at Deutsche Bank... Equity Residential (EQR) initiated with a Neutral at Mizuho... Essex Property Trust (ESS) initiated with a Buy at Mizuho... Fluor (FLR) initiated with an Outperform at Wells Fargo... Goodyear Tire (GT) initiated with an Overweight at JPMorgan... Hospira (HSP) initiated with a Hold at Deutsche Bank... Host Hotels (HST) initiated with a Neutral at ISI Group... Jacobs Engineering (JEC) initiated with an Outperform at Wells Fargo... Jazz Pharmaceutical initiated with a Buy at Buckingham... Mallinckrodt (MNK) initiated with a Buy at Deutsche Bank... Men's Wearhouse (MW) reinstated with a Buy at Goldman... Mylan (MYL) initiated with a Buy at Deutsche Bank... Parkway Properties (PKY) initiated with a Neutral at Mizuho... Perrigo (PRGO) initiated with a Buy at Deutsche Bank... Salix (SLXP) initiated with a Hold at Deutsche Bank... Teva (TEVA) initiated with a Buy at Deutsche Bank... Valeant (VRX) initiated with a Hold at Deutsche Bank... Ventas (VTR) initiated with a Buy at Mizuho.
News For ACT;ARCP;BDN;BR;CBI;CTB;DRH;ENDP;EQR;ESS;GT;HSP;HST;JEC;MNK;MW;MYL;PKY;PRGO;SLXP;TEVA;VRX;VTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
October 8, 2014
07:19 EDTMNKCBI to hold a conference
Subscribe for More Information
06:47 EDTMYL, TEVA, ACTLawmakers may push for new regulations on generic drug makers, NY Times says
After the prices of some generic drugs soared more than 1,000% over the last year, two influential members of Congress are probing the sector and threatening to look to impose new regulations on it, according to The New York Times. Generic drug makers include Teva (TEVA), Mylan (MYL), Actavis (ACT), and Lannett (LCI).Reference Link
06:26 EDTCTBCooper Tire to sell 65% stake in JV to Chengshan Group, WSJ reports
Cooper Tire will sell its 65% stake in its Cooper Chenghsan Tire joint venture to Chengshan Group for $284.5M, the Wall Street Journal reports. The deal requires approval from China's commerce ministry and other authorities. Reference Link
06:23 EDTSLXP, VRX, ACTActavis more inclined to pursue Allergan over Salix, says Citigroup
Subscribe for More Information
October 7, 2014
18:29 EDTVRXOn The Fly: After Hours Movers
Subscribe for More Information
18:05 EDTVRXValeant, Pershing Square plan to raise Allergan bid by $15 a share, WSJ says
Subscribe for More Information
17:52 EDTVRXAllergan up 2.8% after Dow Jones says Valeant planning to boost bid for company
17:49 EDTVRXValeant up 3.9% after Dow Jones says planning to boost Allergan bid
Subscribe for More Information
17:47 EDTVRXValeant, Pershing Square planning to boost Allergan bid by $15 a share, DJ says
Subscribe for More Information
16:07 EDTPKYParkway Properties announces agreement to sell portfolio of buildings for $237M
Parkway Properties announced that it has reached an agreement to sell a portfolio of 19 office buildings for a gross sale price of $237.0M. Parkway recently agreed to purchase the 19 office assets, which are located in six states and total approximately 2.1M square feet, as part of the same transaction pursuant to which Parkway has agreed to acquire Corporate Center I, II, and III at International Plaza located in the Westshore submarket of Tampa, Florida. The 19 office assets that Parkway has agreed to sell are not consistent with Parkway's current investment strategy. As part of the agreement, the prospective buyer posted a $10.0M earnest money deposit. Parkway expects the closing of the sale of the 19 office portfolio to occur during Q4.
15:21 EDTSLXP, ACT, VRXAllergan warms to sale as Actavis plans new approach, Reuters says
Subscribe for More Information
15:01 EDTACTAllergan up 1.5% following report on Actavis planned approach on merger
14:59 EDTACTActavis plans new approach to Allergan, Reuters reports
Subscribe for More Information
10:56 EDTMYLOptions with increasing implied volatility
Subscribe for More Information
08:01 EDTCBIChicago Bridge & Iron signs $90M contract to overhaul five oil storage tanks
Subscribe for More Information
07:48 EDTSLXP, ACTSalix reinstated with a Buy at Jefferies
Subscribe for More Information
07:46 EDTJECJacobs recieves contract from CBBT
Jacobs Engineering announced that it was awarded a contract from the Chesapeake Bay Bridge and Tunnel Commission to serve as the design manager for a new tunnel along the 23-mile toll crossing at Thimble Shoals Channel between Virginia Beach, Virginia, and the Delmarva Peninsula. Company officials did not disclose the contract value. Under the terms of the design management contract, Jacobs is completing project development, including the tunnel, associated bridges, and artificial islands, to support the Districtís design-build procurement. Jacobs is also managing procurement and providing support to the CBBT in reviewing technical requirements of the design-build proposals and final award of the design-build contractor.
07:46 EDTJECJacobs Engineering awarded contract option at NASA Kennedy Space Center
Subscribe for More Information
07:12 EDTVRXAllergan requests Ackman be hindered from voting at meeting, Bloomberg says
In an effort to avoid an unsolicited $54B acquisition offer from Valeant Pharmaceuticals (VRX), Allergan (AGN) filed a request in a California court for a judge to hinder Bill Ackmanís Pershing Square from voting its 10% stake at the December shareholder meeting, according to Bloomberg, citing the filing. A hearing regarding Allergan's request is set to occur on October 28. Reference Link
07:06 EDTHSPOmeros, Hospira enter into commercial suply agreement for Omidria
Omeros Corporation (OMER) said in a filing that on October 3, it, Hospira S.p.A. and Hospira Worldwide, Inc. (HSP) entered into a Commercial Supply Agreement, pursuant to which Hospira will act as a non-exclusive supplier of Omerosí product Omidria for commercial sale in the United States and the European Union. Pursuant to the Supply Agreement, Hospira has agreed to manufacture and supply, and Omeros has agreed to purchase, a minimum percentage of Omerosí requirements of Omidria for commercial sales and clinical supplies for the development of additional therapeutic indications in the United States. In addition, upon receipt of marketing approval in the EU, Hospira has agreed to manufacture and supply a portion of Omerosí requirements of Omidria in the EU in an amount to be mutually agreed by the parties within four months of marketing approval in Europe, with there being no minimum purchase and supply requirement in the EU if the parties do not reach agreement during such time period and the agreement is not amended thereafter. The Supply Agreement obligates Omeros to provide to Hospira a rolling, non-binding long-term forecast of Omerosí estimated required quantities of Omidria. The Supply Agreement has an initial term of five years from the date of first commercial sale of Omidria in any country in the Territory. Upon termination of the Supply Agreement, except in the case of termination for an uncured breach by Hospira, Omeros will be required to purchase all of Hospiraís inventory of Omidria and, if applicable, work in progress and reimburse Hospira for all supplies purchased or ordered based on firm purchase orders or Omerosí estimates of its requirements of Omidria.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use